Erasmus School of Health Policy & Management
Visiting fellow | Health Technology Assessment (HTA)
- bosch@eshpm.eur.nl
More information
Work
- Dianne Bosch, Kim J.M. van der Velden, Tom Belleman, Welmoed K. van Deen, André M Bergman, Maarten J. van der Doelen, Alfons J M van den Eertwegh, Winald R Gerritsen, Reindert J A van Moorselaar, Diederik M. Somford, Metin Tascilar, Hans M. Westgeest, Carin A Uyl-de Groot, Peter F.A. Mulders, Malou C.P. Kuppen & Inge M. van Oort (2025) - Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Clinical Genitourinary Cancer, 23 (3) - doi: 10.1016/j.clgc.2025.102317 - [link]
- Tom Belleman, Jeroen van Wijngaarden, Malou C.P. Kuppen, Saskia de Groot, Kim J. M. van der Velden, Dianne Bosch, Inge M. van Oort, Carin Uyl - de Groot & Welmoed van Deen (2025) - Moving from a registry to a learning health system: A casestudy of a Dutch prostate cancer registry - Learning Health Systems, 9 (3) - doi: 10.1002/lrh2.10476 - [link]
- Dianne Bosch, Malou C.P. Kuppen, Metin Tascilar, Tineke J. Smilde, Peter F.A. Mulders, Carin A. Uyl-de Groot & Inge M. van Oort (2023) - Reliability and Efficiency of the CAPRI-3 Metastatic Prostate Cancer Registry Driven by Artificial Intelligence - Cancers, 15 (15) - doi: 10.3390/cancers15153808 - [link]
